Storia in 2 fonti

Biocon to see block deals, as Viatris plans to exit

Viatris plans to sell a 5.64% stake in Biocon at a 7.9% discount, marking a complete exit.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mese fa

Biocon to see block deals, as Viatris plans to exit

Viatris plans to sell a 5.64% stake in Biocon at a 7.9% discount, marking a complete exit.

originale

economictimes.indiatimes.com1 mese fa

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represents 5.64% of Biocon's outstanding shares.…

Leggi questa versione → originale

Timeline cronologica

lunedì 13 luglio 2026·thehindubusinessline.com
Biocon to see block deals, as Viatris plans to exit
Viatris plans to sell a 5.64% stake in Biocon at a 7.9% discount, marking a complete exit.
martedì 14 luglio 2026·economictimes.indiatimes.com
Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale
Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale…

Biocon to see block deals, as Viatris plans to exit

Confronto fonti

Biocon to see block deals, as Viatris plans to exit

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Timeline cronologica

Biocon to see block deals, as Viatris plans to exit

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Rs 1,839 crore Biocon block deal: ICICI Pru MF biggest buyer along with Citi and Goldman Sachs

Mylan exits Biocon with ₹3,679-crore stake sale; Biocon shares jump over 6%